November, 2025
November 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Balancing Bleeding and Clotting Risks: Updated LP Guidelines in Antithrombotic Care- by Dr. Chokri Ben Lamines
Jun 2, 2025, 06:45

Balancing Bleeding and Clotting Risks: Updated LP Guidelines in Antithrombotic Care- by Dr. Chokri Ben Lamines

Updated Peri-Procedural Guidelines at a Glance on X։

Explore Dr. Chokri Ben Lamine’s evidence-based guide on safely performing lumbar puncture in patients receiving anticoagulants or antiplatelet therapy. This concise reference outlines when to pause, bridge, or proceed—based on the latest international recommendations․

“Lumbar Puncture & Bleeding Risk: Summary

-When to stop or continue common agents (aspirin, warfarin, DOACs)
-Risk stratification for bleeding vs. thrombosis
-Bridging protocols for high-risk patients
-Practical timing for safe LP execution

Stop Antithrombotics Before LP

Antiplatelets

• Aspirin 75mg: Continue
• Clopidogrel: 7d (aspirin cover) → LP after 6h
• Prasugrel/Ticagrelor: 7d → LP after 6h
• Dipyridamole: 24h → LP after 6h
• Tirofiban/Eptifibatide: 4–8h → LP after 4h
• Abciximab: 48h → LP after 24h

Anticoagulants

• Warfarin: 5d → INR ≤1.4 → LP → restart 12h
• LMWH (proph): 12h → LP → restart 4h
• LMWH (Tx): 24h → LP → restart 4h (24h if traumatic)
• Fondaparinux (proph): 36h → LP → restart 6–12h
• Fondaparinux (Tx): Avoid LP
• UFH IV: –6h → LP → restart 1h
• Rivaroxaban/Apixaban: 24h → LP → restart 6h
• Dabigatran: 48h → LP → restart 6h”

For fast answers to nuanced clinical questions, visit Hemostasis Today.